[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100496519":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":91,"collaborators":94,"id":97,"slug":98,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":18,"eligibilityCriteria":103,"healthyVolunteers":99,"sex":104,"minAge":105,"maxAge":18,"enrollmentInfo":106,"targetDuration":18,"studyType":109,"phases":110,"briefSummary":112,"conditions":113,"keywords":119,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":130},{"fullName":5,"class":6},"University of Miami","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"LLS Program and Usual Care Group","EXPERIMENTAL","Participants in the LLS Program and Usual Care condition will receive LLS services such as information, services, and financial aid so that patients can have better access to healthcare and better quality of life. Participants will also receive the standard care. Participants will be in this group for 6 months.",[13],"Other: LLS Program",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care Group","NO_INTERVENTION","Participants will receive the standard care. Participants will be in this group for 6 months.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"LLS Program","The intervention will be conducted virtually. Participants will receive LLS's free patient and caregiver services including co-pay assistance, transportation and urgent need assistance, a scholarship program for young adult patients and survivors, one-on-one peer-to-peer support, online chats and support groups facilitated by clinical social workers, and nutrition counseling with a registered dietician for 6 months.",[9],[25],{"name":26,"affiliation":5,"role":27},"Frank Penedo, PhD","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Carlos Melara, MD","CONTACT","3052438300","cam32407@med.miami.edu",{"name":35,"role":31,"phone":18,"phoneExt":18,"email":36},"Sara Fleszar-Pavlovic, PhD","sarafleszarpavlovic@med.miami.edu",[38,58,75],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Sylvester Comprehensive Cancer Center","RECRUITING","Miami","Florida","33136","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-80.19366,25.77427,{"lat":50,"lon":49},[53,57],{"name":54,"role":31,"phone":55,"phoneExt":18,"email":56},"Madeline Krause, MSEd","305-243-3329","mkrause@miami.edu",{"name":26,"role":27,"phone":18,"phoneExt":18,"email":18},{"facility":59,"status":60,"city":61,"state":62,"zip":63,"country":44,"countryCode":45,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"University of Chicago Comprehensive Cancer Center","NOT_YET_RECRUITING","Chicago","Illinois","60637",{"type":47,"coordinates":65},[66,67],-87.65005,41.85003,{"lat":67,"lon":66},[70,74],{"name":71,"role":31,"phone":72,"phoneExt":18,"email":73},"Mariam Nawas, MD","773-702-6149","nawasm@bsd.uchicago.edu",{"name":71,"role":27,"phone":18,"phoneExt":18,"email":18},{"facility":76,"status":60,"city":77,"state":78,"zip":79,"country":44,"countryCode":45,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Mays Cancer Center at UT Health San Antonio","San Antonio","Texas","78229",{"type":47,"coordinates":81},[82,83],-98.49363,29.42412,{"lat":83,"lon":82},[86,90],{"name":87,"role":31,"phone":88,"phoneExt":18,"email":89},"Patricia Chalela, DrPH","210-562-6513","chalela@uthscsa.edu",{"name":87,"role":27,"phone":18,"phoneExt":18,"email":18},{"type":27,"investigatorFullName":92,"investigatorTitle":93,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Frank Penedo","Professor",[95],{"name":96,"class":6},"Blood Cancer United","100496519","leukemia-and-lymphoma-society-lls-services-impact-on-outcomes-and-care-100496519",false,"NCT05745285","Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care","The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial","Inclusion Criteria:\n\n* Be diagnosed with, or have a recurrence of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN).\n* Have received, be receiving, or be planning to receive primary or relapse treatment for leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN) and meet at least one of the following criteria:\n\n  * Be currently receiving treatment which started within the past 18 months OR\n  * Be planning to start treatment within one month OR\n  * Have received Bone Marrow Transplant or CAR-T cell therapy within the past 100 days.\n* Not be currently participating in any LLS programs or services\n* Be willing to be followed for 6 months\n* Speak English or Spanish\n\nExclusion Criteria:\n\n* Are not diagnosed with, or have a recurrence of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)\n* Do not meet at least one of the following criteria if treated or planning to get treated for leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN):\n\n  * Be currently receiving treatment which started within the past 18 months OR\n  * Be planning to start treatment within one month OR\n  * Have received Bone Marrow Transplant or CAR-T cell therapy within the past 100 days.\n* Are currently participating in any LLS programs or services\n* Are not willing to be followed for 6 months\n* Do not speak English or Spanish.","ALL","18 Years",{"count":107,"type":108},400,"ESTIMATED","INTERVENTIONAL",[111],"NA","The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.",[114,115,116,117,118],"Leukemia","Lymphoma","Myeloma","Myelodysplastic Syndromes","Myeloproliferative Neoplasm",[120],"Blood cancer","2026-02-18",{"date":123,"type":124},"2026-02-20","ACTUAL",{"date":126,"type":124},"2025-02-04",{"date":128,"type":108},"2026-11-01",{"name":5,"class":6},3]